Hôpital Saint Louis
Paris, 75010, France
NCT Number: NCT01219972
This is a prognostic study of the late lung complications arising at the patient's having received an allograft of hematopoetic stem cells.
Looking for future studies?
Notify MeAll sexes
Observational
Paris, 75010, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
Time frame: 3 years and 10 years
Time frame: 3 years and 10 years
Time frame: 3 years and 10 years
Assistance Publique - Hôpitaux de Paris
Other
Prospective Cohort Study of Late Pulmonary Complications in Patients Who Received Allogeneic Hematopoietic Stem Cells Transplantation: Estimation of Incidence and Identification of Distinct Nosologic Entities
Acronym: ALLOPULM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07041567
Atelectasis, Bariatric Surgery
Istanbul, Goztepe, Turkey (Türkiye)
View Trial DetailsNCT07187232
PreTerm Neonate, Pulmonary Complications
Changhua, Taiwan
View Trial DetailsNCT02739841
Pulmonary Complications
Khon Kaen, Thailand
View Trial DetailsNCT02627742
Atelectasis, Lung Diseases
Burlington, Massachusetts, United States
View Trial Details